Longeveron Inc. (LGVN)

NASDAQ: LGVN · Real-Time Price · USD

0.8090

-0.0035 (-0.43%)

At close: Mar 12, 2026, 4:00 PM EDT

0.8559

+0.0469 (5.80%)

Pre-market: Mar 13, 2026, 9:17 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Biotechnology	2.39M	709.00K	1.22M	1.31M	5.63M
Biotechnology Growth	237.38%	-41.98%	-6.43%	-76.80%	-0.19%
Total	2.39M	709.00K	1.22M	1.31M	5.63M
Total Growth	237.38%	-41.98%	-6.43%	-76.80%	-0.19%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	2.39M	709.00K	1.22M	1.31M	5.63M
United States Growth	237.38%	-41.98%	-6.43%	-76.80%	-0.19%
Total	2.39M	709.00K	1.22M	1.31M	5.63M
Total Growth	237.38%	-41.98%	-6.43%	-76.80%	-0.19%

Source: S&P Global Market Intelligence.